| Biological Information | |
|---|---|
| Background Information: | N-terminal 6His-tagged, recombinant, human SLK, amino acids 1-373. SLK is a member of the serine/threonine protein kinase family. Mediates organ development, cell cycle progression, cytoskeletal remodeling, cytokinesis, apoptosis, actin stress fiber dissolution and cell survival. |
| Target Class: | Kinase |
| Family: | STE (Ser/thr protein kinase) |
| Sub Family: | Serine/threonine kinase |
| Accession Number: | BC111565.1 |
| Target Name: | SLK |
| Target Aliases: | MGC133067, STK2, KIAA0204, SLK, bA16H23.1, se20-9, hSLK, STE20-like serine/threonine-protein kinase STE20-like kinase CTCL tumor antigen se20-9 STE20-related serine/threonine-protein kinase STE20-related kinase Serine/threonine-protein kinase 2, Q9H2G2 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 12 months at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Biochemical |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
SLK, active
10 µg of active SLK. N-terminal 6His-tagged, recombinant, human SLK, amino acids 1-373.
Datasheets
15-027_Datasheet
View Document